Kontour Medical(SH:688314) Xin Lang Cai Jing·2025-09-03 05:47Company Overview - Kangtuo Medical, established on March 14, 2005, is located in Xi'an, Shaanxi Province, and was listed on May 18, 2021. The company specializes in the research, production, and sales of three types of implantable medical devices [1] - The company's main business revenue composition includes: PEEK material neurosurgical products (63.86%), titanium material neurosurgical products (22.54%), other products (10.97%), and supplementary products (2.62%) [1] Stock Performance - On September 3, Kangtuo Medical's stock rose by 5.04%, reaching a price of 38.16 CNY per share, with a trading volume of 71.24 million CNY and a turnover rate of 2.36%. The total market capitalization is 3.1 billion CNY [1] Fund Holdings - Dongxing Fund has a significant holding in Kangtuo Medical, with its Dongxing Pharmaceutical Biotechnology Quantitative Selection Mixed A Fund (020830) holding 6,653 shares, accounting for 3.51% of the fund's net value, making it the sixth-largest holding [2] - The fund has achieved a year-to-date return of 36.69%, ranking 1474 out of 8180 in its category, and a cumulative return of 29.01% since its inception [2] Fund Manager Profile - The fund manager of Dongxing Pharmaceutical Biotechnology Quantitative Selection Mixed A Fund is Li Bingwei, who has been in the position for 9 years and 85 days. The total asset size of the fund is 352 million CNY, with the best return during his tenure being 62.49% and the worst being -11.19% [3]